LNAI
Lunai Bioworks Inc.NASDAQHealthcare$0.37-24.40%ClosedMarket Cap: $6.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.49
P/S
0.00
EV/EBITDA
-0.95
DCF Value
$-1.32
FCF Yield
-114.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-1241.3%
ROA
-1882.9%
ROIC
116.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $0.00 | -Infinity% | $-1.8M | $-1.8M | $-0.08 | — |
| Q1 2025 | $0.00 | -Infinity% | $-2.5M | $2.8M | $0.13 | — |
| Q4 2024 | $0.00 | -Infinity% | $-4.1M | $-126.7M | $-7.61 | — |
| FY 2024 | $0.00 | -Infinity% | $-18.5M | $-178.0M | $-10.78 | — |
| Q3 2024 | $0.00 | NaN% | $-4.2M | $189.2K | $0.01 | — |
| Q2 2024 | $0.00 | NaN% | $-4.5M | $-7.3M | $-0.40 | — |
| Q1 2024 | $0.00 | NaN% | $-53.3M | $-44.2M | $-2.80 | — |
| Q4 2023 | $0.00 | NaN% | $-51.3M | $-49.9M | $-3.88 | — |
| FY 2023 | $0.00 | NaN% | $-81.6M | $-88.4M | $-9.10 | — |
| Q3 2023 | $0.00 | -Infinity% | $-8.8M | $-59.0M | $-5.40 | — |
| Q2 2023 | $0.00 | -Infinity% | $-4.3M | $-4.5M | $-0.69 | — |
| FY 2022 | $0.00 | NaN% | $-38.6M | $-39.7M | $-7.10 | — |